JP2005325333A - Polypropylene-based resin composition and outer cylinder of syringe made of the same - Google Patents

Polypropylene-based resin composition and outer cylinder of syringe made of the same Download PDF

Info

Publication number
JP2005325333A
JP2005325333A JP2005057114A JP2005057114A JP2005325333A JP 2005325333 A JP2005325333 A JP 2005325333A JP 2005057114 A JP2005057114 A JP 2005057114A JP 2005057114 A JP2005057114 A JP 2005057114A JP 2005325333 A JP2005325333 A JP 2005325333A
Authority
JP
Japan
Prior art keywords
resin composition
polypropylene
weight
ethylene
outer cylinder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005057114A
Other languages
Japanese (ja)
Other versions
JP4808419B2 (en
Inventor
Isao Wada
功 和田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Chemicals Inc
Original Assignee
Mitsui Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Chemicals Inc filed Critical Mitsui Chemicals Inc
Priority to JP2005057114A priority Critical patent/JP4808419B2/en
Publication of JP2005325333A publication Critical patent/JP2005325333A/en
Application granted granted Critical
Publication of JP4808419B2 publication Critical patent/JP4808419B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a polypropylene-based resin composition whose transparency and impact resistance are simultaneously improved with a good balance and that has such an excellent property that its rigidity decrease is very low and whose impact resistance is hardly decreased by γ-ray irradiation and that is cheap, and to provide an outer cylinder of a syringe made of the resin composition. <P>SOLUTION: The polypropylene-based resin composition is produced by further control of total MFR(230°C) at 25-40 g/10 min by an added peroxide-induced thermal decomposition of a resin composition comprised of a 100 pts.wt. resin mixture, that comprises a 97-99.6 wt% polypropylene(A) whose MFR(230°C) is 4-20 g/10 min and ethylene content is 3.6-4.2 wt% and an 0.4-3 wt% ethylene/6-8C-α-olefin copolymer(B) whose MFR(190°C) is 2-6 g/10 min and density is not more than 0.850-0.870 g/cm<SP>3</SP>, and a 0.05-0.5 pts.wt. specified nucleus forming agent, and the outer cylinder of the syringe is made of the resin composition. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、透明性および耐衝撃性に優れたポリプロピレン系樹脂組成物並びにその組成物から形成された医療用器具、特に注射器外筒に関する。さらに特徴的にはγ線や電子線による処理後の運搬や不意の落下にも耐えうるポリプロピレン系樹脂組成物に関する。   The present invention relates to a polypropylene resin composition excellent in transparency and impact resistance, and a medical instrument formed from the composition, particularly a syringe outer cylinder. More specifically, the present invention relates to a polypropylene-based resin composition that can withstand transportation after γ-ray or electron beam treatment and unexpected drop.

一般にポリプロピレン樹脂は、化学的特性、物理的特性、および成形加工性に優れ、しかも安価であることから、食品容器や医薬品容器を初めとした広範囲の用途に利用されている。しかしながら、ポリプロピレン樹脂それ自体では、透明性や機械的強度特性が必ずしも十分でないため、通常ポリプロピレン樹脂に種々の造核剤を添加して透明性や機械的強度特性を向上させ、またゴム成分を多量添加して耐衝撃性を向上させる方法がとられているが、ゴムは非常に高価であり、高コストとなる。   In general, polypropylene resins are used in a wide range of applications including food containers and pharmaceutical containers because they are excellent in chemical characteristics, physical characteristics, and moldability, and are inexpensive. However, since the polypropylene resin itself does not necessarily have sufficient transparency and mechanical strength characteristics, various nucleating agents are usually added to the polypropylene resin to improve transparency and mechanical strength characteristics, and a large amount of rubber component is used. Although a method for improving impact resistance by adding is used, rubber is very expensive and expensive.

公知事象として特開2002−226649に記載の組成では非常に高価な組成となり、低コストで且つ透明性と耐衝撃性と剛性を満足はできなかった。   As a known event, the composition described in Japanese Patent Application Laid-Open No. 2002-226649 was very expensive and could not satisfy transparency, impact resistance and rigidity at a low cost.

透明性を向上させるために造核剤を添加する方法、耐衝撃性を付与するために非晶性エチレン・プロピレン共重合体を添加する方法、あるいはポリプロピレン樹脂としてプロピレン・エチレンブロック共重合体を使用する方法では、透明性や剛性、または耐衝撃性のいずれかの性能付与は達成できても、すべてを同時に満足させることは難しい。   A method of adding a nucleating agent to improve transparency, a method of adding an amorphous ethylene / propylene copolymer to impart impact resistance, or a propylene / ethylene block copolymer as a polypropylene resin In this method, it is difficult to satisfy all of them simultaneously, even if the performance of transparency, rigidity, or impact resistance can be achieved.

また、一般に良く用いられる医療用器具用ポリプロピレンとしては、高エチレン含有量のエチレン−プロピレンランダム共重合体が用いられるが、これを用いた医療用器具は、γ線滅菌後、不意の落下や針の装着時にγ線により耐衝撃性が極度に低下し、特に冬場での割れが発生するという問題があった。
特開2002−226649号公報
In addition, as a commonly used polypropylene for medical devices, an ethylene-propylene random copolymer having a high ethylene content is used, and medical devices using this are used for unexpected drops and needles after γ-ray sterilization. There was a problem that the impact resistance was extremely lowered by γ-rays at the time of wearing, and cracking occurred particularly in winter.
JP 2002-226649 A

本発明は、従来得る事のできなかった透明性と耐衝撃性と剛性を同時にバランスよく向上させ、且つ経済性に優れたポリプロピレン系樹脂組成物の提供を目的とする。また本発明は、電子線やγ線により耐衝撃性が低下しにくいポリプロピレン系樹脂組成物の提供を目的とする。   An object of the present invention is to provide a polypropylene-based resin composition that improves transparency, impact resistance, and rigidity, which could not be obtained conventionally, in a well-balanced manner and is excellent in economic efficiency. Another object of the present invention is to provide a polypropylene-based resin composition whose impact resistance is not easily lowered by electron beams or γ rays.

さらに本発明は、その樹脂組成物から射出成形によって注射器外筒に成形され、電子線やγ線による滅菌処理が行われた後も割れ問題を解決できる注射器外筒の提供を目的とする。   A further object of the present invention is to provide a syringe outer cylinder that can be molded from a resin composition by injection molding into a syringe outer cylinder and that can solve the cracking problem even after sterilization with an electron beam or γ-ray.

本発明は、(A)MFR(230℃)が4〜20g/10分、エチレン含有量が3.6〜4.2重量%のポリプロピレン97〜99.6重量%、(B)MFR(190℃)が2〜6g/10分であり、かつ密度が0.850〜0.870g/cm以下であるエチレンと炭素数6〜8のα-オレフィンとの共重合体0.4〜3重量%、とからなる樹脂混合物100重量部当たり、下記式(1)で表わされる造核剤を0.05〜0.5重量部配合して更に過酸化物配合・熱分解により、更に全MFR(230℃)が25〜40g/10分に分子量コントロールとからなるポリプロピレン系樹脂組成物に関する。 In the present invention, (A) MFR (230 ° C.) is 4 to 20 g / 10 minutes, ethylene content is 3.6 to 4.2% by weight, polypropylene 97 to 99.6% by weight, (B) MFR (190 ° C. ) Is a copolymer of ethylene and an α-olefin having 6 to 8 carbon atoms having a density of 2 to 6 g / 10 min and a density of 0.850 to 0.870 g / cm 3 or less. And 0.05 to 0.5 parts by weight of a nucleating agent represented by the following formula (1) per 100 parts by weight of the resin mixture comprising: ° C) relates to a polypropylene resin composition having a molecular weight control of 25 to 40 g / 10 min.

Figure 2005325333
Figure 2005325333

本発明は、前記のポリプロピレン系樹脂組成物に、さらにリン系酸化防止剤(C)0.05〜0.3重量部およびアミン系酸化防止剤(D)0.01〜0.3重量部が含有されたポリプロピレン系樹脂組成物を提供する。   In the present invention, the polypropylene resin composition further comprises 0.05 to 0.3 parts by weight of a phosphorus antioxidant (C) and 0.01 to 0.3 parts by weight of an amine antioxidant (D). Provided is a polypropylene-based resin composition.

さらに本発明は、前記のポリプロピレン系樹脂組成物から形成されてなることを特徴とする注射器外筒を提供する。 Furthermore, the present invention provides a syringe outer cylinder formed from the above-described polypropylene resin composition.

注射器外筒が、特に電子線、γ線照射による滅菌を施される注射器外筒に好適である。   The syringe barrel is particularly suitable for a syringe barrel that is sterilized by electron beam and γ-ray irradiation.

非常に狭い組成範囲でのみこのような良好な透明性を保持した上に、γ線照射後も高い耐衝撃性と剛性をバランスでき、且つ低コストという今までに無い材料を開発できた。5℃での耐衝撃性が飛躍的に改良できており、冬場の割れ問題、針装着時の折れ問題を解決でき、この材料は、安価な使い捨て注射器外筒に好適である。   In addition to maintaining such good transparency only in a very narrow composition range, it has been possible to develop an unprecedented material that can balance high impact resistance and rigidity after γ-ray irradiation and is low in cost. The impact resistance at 5 ° C. can be drastically improved, and it can solve the problem of cracking in winter and the problem of breakage at the time of wearing a needle, and this material is suitable for an inexpensive disposable syringe outer cylinder.

本発明に係わるプロピレン系樹脂組成物およびそれから形成し、電子線、γ線照射による滅菌を施す用途に好適な注射器外筒について、より具体的に説明する。   The propylene-based resin composition according to the present invention and the syringe outer tube formed therefrom and suitable for use for sterilization by electron beam and γ-ray irradiation will be described more specifically.

本発明のプロピレン系樹脂組成物は、(A)メルトフローレートMFR(230℃)が4〜20g/10分、エチレン含有量が3.6〜4.2重量%のポリプロピレン97〜99.6重量%、(B)MFR(190℃)が2〜6g/10分であり、かつ密度が0.850〜0.870g/cm以下であるエチレンと炭素数6〜8のα−オレフィンとの共重合体0.4〜3重量%、とからなる樹脂混合物100重量部当たり、(C)前記式(1)で表わされる造核剤を0.05〜0.5重量部配合して過酸化物配合・熱分解により、更に全MFR(230℃)が25〜40g/10分に分子量コントロールしたことを特徴とするポリプロピレン系樹脂組成物である。 The propylene-based resin composition of the present invention has (A) a melt flow rate MFR (230 ° C.) of 4 to 20 g / 10 min and an ethylene content of 3.6 to 4.2% by weight of 97 to 99.6% of polypropylene. %, (B) MFR (190 ° C.) of 2 to 6 g / 10 min and a density of 0.850 to 0.870 g / cm 3 or less of ethylene and an α-olefin having 6 to 8 carbon atoms. (C) 0.05 to 0.5 parts by weight of a nucleating agent represented by the formula (1) per 100 parts by weight of a resin mixture consisting of 0.4 to 3% by weight of a polymer and a peroxide A polypropylene resin composition characterized in that the molecular weight of the total MFR (230 ° C.) is further controlled to 25 to 40 g / 10 minutes by blending and thermal decomposition.

(A)ポリプロピレン
(A)ポリプロピレンは、プロピレンとエチレンとのランダム共重合体である。このポリプロピレンのメルトフローレート値(MFR(230℃))は、4〜20g/10分、好ましくは8〜20g/10分、より好ましくは8〜12g/10分である。また、赤外吸収スペクトルで測定したエチレン含有量が3.6〜4.2重量%、好ましくは3.8〜4.0重量%であることが望ましい。
(A) Polypropylene (A) Polypropylene is a random copolymer of propylene and ethylene. The polypropylene has a melt flow rate value (MFR (230 ° C.)) of 4 to 20 g / 10 minutes, preferably 8 to 20 g / 10 minutes, and more preferably 8 to 12 g / 10 minutes. Further, it is desirable that the ethylene content measured by infrared absorption spectrum is 3.6 to 4.2% by weight, preferably 3.8 to 4.0% by weight.

メルトフローレートおよびエチレン含有量が前記の範囲内にあると、樹脂の流動性(成形性)および機械的強度のバランスが良好になり、見映えの良い外観を持った成形品が得られる。メルトフローレートが4以下のポリプロピレンを用いると、樹脂酸化劣化による少しの黄色みを帯び、外観が良くない。また、FDA基準記載のt−ブタノール発生量が大幅に増加し、好ましくない。また、エチレン含有量が前記の範囲外の場合、剛性と耐衝撃性のバランスが保てない。   When the melt flow rate and the ethylene content are within the above ranges, the resin fluidity (moldability) and mechanical strength are well balanced, and a molded product having a good appearance can be obtained. When polypropylene having a melt flow rate of 4 or less is used, the appearance is not good due to a slight yellowishness due to resin oxidation deterioration. In addition, the amount of t-butanol generated according to the FDA standards is greatly increased, which is not preferable. Further, when the ethylene content is outside the above range, the balance between rigidity and impact resistance cannot be maintained.

このようなポリプロピレンは、チタン系またはジルコニウム系などの遷移金属化合物成分、有機アルミニウム成分、必要に応じて電子供与体、担体等を含む立体規則性オレフィン重合触媒の存在下に、プロピレンと必要量に応じたエチレンの共存下で重合させることによって製造することができる。 Such polypropylene is produced in the required amount of propylene in the presence of a stereoregular olefin polymerization catalyst containing a transition metal compound component such as titanium or zirconium, an organoaluminum component, an electron donor, a carrier, etc., if necessary. It can be produced by polymerizing in the presence of the corresponding ethylene.

(B)エチレン・α−オレフィン共重合体
(B)エチレン・α−オレフィン共重合体は、エチレンと炭素数6〜8のα−オレフィンとの共重合体であって、密度が0.850〜0.870g/cmであって、この範囲内にあると共重合体は良好なゴム的性質を示す。
(B) Ethylene / α-olefin copolymer (B) The ethylene / α-olefin copolymer is a copolymer of ethylene and an α-olefin having 6 to 8 carbon atoms, and has a density of 0.850 to When it is 0.870 g / cm 3 and is within this range, the copolymer exhibits good rubber properties.

この共重合体(B)のメルトフローレート値(MFR(190℃))は、2〜6、好ましくは3〜4g/10分である。また、この共重合体の密度は特に0.850〜0.870(g/cm)であることが好ましい。この密度及びMFR範囲内にあると、共重合体は良好なゴム弾性を保持したまま、エチレン−ポリプロピレンランダム共重合体に微分散し、透明性に優れる。 The melt flow rate value (MFR (190 ° C.)) of this copolymer (B) is 2 to 6, preferably 3 to 4 g / 10 minutes. Moreover, it is preferable that the density of this copolymer is 0.850-0.870 (g / cm < 3 >) especially. Within this density and MFR range, the copolymer is finely dispersed in the ethylene-polypropylene random copolymer while maintaining good rubber elasticity, and is excellent in transparency.

このようなエチレン・α−オレフィン共重合体は、シクロペンタジエン骨格を有する化合物がジルコニウム金属等の遷移金属に配位したメタロセン化合物と有機アルミニウムオキシ化合物等とを含むメタロセン系触媒などの立体規則性重合触媒の存在下に、エチレンとα−オレフィンとを共重合させて製造することができる。特に、メタロセン系触媒を用いて製造したエチレン・α−オレフィン共重合体は、分子量分布および組成分布が狭いことから、容器用樹脂組成物の原料として適している。   Such an ethylene / α-olefin copolymer is a stereoregular polymerization such as a metallocene catalyst comprising a metallocene compound in which a compound having a cyclopentadiene skeleton is coordinated to a transition metal such as zirconium metal and an organoaluminum oxy compound. It can be produced by copolymerizing ethylene and an α-olefin in the presence of a catalyst. In particular, an ethylene / α-olefin copolymer produced using a metallocene catalyst is suitable as a raw material for a resin composition for containers because of its narrow molecular weight distribution and composition distribution.

本発明においては、前記のエチレン・α−オレフィン共重合体(B)はエチレン・1−オクテン共重合体であるポリプロピレン系樹脂組成物が好ましく使用される。 In the present invention, a polypropylene resin composition in which the ethylene / α-olefin copolymer (B) is an ethylene / 1-octene copolymer is preferably used.

また本発明において、前記のエチレン・α−オレフィン共重合体(B)はメタロセン触媒によって製造された重合体であるポリプロピレン系樹脂組成物が好ましく使用される。   In the present invention, a polypropylene resin composition which is a polymer produced by a metallocene catalyst is preferably used as the ethylene / α-olefin copolymer (B).

(C)造 核 剤
本発明における(C)造核剤は、既に述べた式(1)で表わされる有機機リン酸エステル系化合物が物性バランスや透明性により好適である。
(C) Nucleating Agent As the (C) nucleating agent in the present invention, the organic phosphoric acid ester compound represented by the formula (1) described above is more suitable for the balance of physical properties and transparency.

樹 脂 組 成 物
本発明のポリプロピレン系樹脂組成物は、MFR(230℃)が4〜20g/10分、エチレン含有量が3.6〜4.2重量%のポリプロピレン(A)97〜99.6重量%、MFR(190℃)が2〜6g/10分であり、かつ密度が0.850〜0.870g/cm以下であるエチレンと炭素数6〜8のα−オレフィンとの共重合体(B)0.4〜3重量%、とからなる樹脂混合物100重量部当たり、式(1)で表わされる造核剤(C)を0.05〜0.5重量部配合して過酸化物により、更に全MFR(230℃)が25〜40g/10分に分子量コントロールしたことを特徴とするポリプロピレン系樹脂組成物。各成分が前記の範囲内にあると、樹脂組成物の透明性を高い水準に保った上で、同時に耐衝撃性の向上を図ることが出来る。
Resin Composition The polypropylene resin composition of the present invention has a MFR (230 ° C.) of 4 to 20 g / 10 min and an ethylene content of 3.6 to 4.2% by weight of polypropylene (A) 97 to 99. Copolymerization of ethylene having 6 wt%, MFR (190 ° C.) of 2 to 6 g / 10 min and a density of 0.850 to 0.870 g / cm 3 or less and an α-olefin having 6 to 8 carbon atoms Peroxidation by adding 0.05 to 0.5 parts by weight of the nucleating agent (C) represented by the formula (1) per 100 parts by weight of the resin mixture consisting of 0.4 to 3% by weight of the union (B). The polypropylene resin composition, wherein the molecular weight of the total MFR (230 ° C.) was further controlled to 25 to 40 g / 10 min. When each component is within the above range, the transparency of the resin composition can be maintained at a high level, and at the same time, the impact resistance can be improved.

本発明のポリプロピレン系樹脂組成物は後述する(F)過酸化物による分子量コントロールを行うので、副生成物としてt−ブタノールが生成する。このt−ブタノールを110℃12時間ペレット乾燥することにより100ppm以下にコントロールすることで米国食品医薬品局(FDA)基準にも対応していることを特徴としている。 Since the polypropylene-based resin composition of the present invention performs molecular weight control by (F) peroxide described later, t-butanol is generated as a by-product. This t-butanol is characterized by being compliant with US Food and Drug Administration (FDA) standards by controlling it to 100 ppm or less by pellet drying at 110 ° C. for 12 hours.

また、上記した本発明のポリプロピレン系樹脂組成物生産時には、後述する(D)リン系酸化防止剤および/または(E)アミン系酸化防止剤を含有する組成物である態様が好適である。MFR(230℃)が4〜20g/10分、エチレン含有量が3.6〜4.2重量%のポリプロピレン(A)97〜99.6重量%、MFR(190℃)が2〜6g/10分であり、かつ密度が0.850〜0.870g/cm以下であるエチレンと炭素数6〜8のα−オレフィンとの共重合体(B)0.4〜3重量%、とからなる樹脂混合物100重量部当たり、造核剤(C)を0.05〜0.5重量部配合し、更にリン系酸化防止剤(D)0.05〜0.2重量部、好ましくは0.1〜0.15重量部、アミン系酸化防止剤(E)0.01〜0.1重量部、好ましくは0.03〜0.06重量部、中和剤としてステアリン酸カルシウムやハイドロタルサイトを0.02〜0.2重量部、好ましくは0.3〜0.7重量部、さらに過酸化物、特に2,5−ジメチル−2,5−ジ(t−ブチルパーオキシ)ヘキサンを加えて押出機により分子量コントロールを行い、全MFR(230℃)を25〜40g/10分に分子量コントロールしたことを特徴とするポリプロピレン系樹脂組成物である。 Moreover, at the time of production of the polypropylene resin composition of the present invention described above, an embodiment which is a composition containing (D) a phosphorus antioxidant and / or (E) an amine antioxidant described later is preferable. MFR (230 ° C.) of 4 to 20 g / 10 minutes, ethylene content of 3.6 to 4.2% by weight of polypropylene (A) 97 to 99.6% by weight, MFR (190 ° C.) of 2 to 6 g / 10 And a copolymer (B) of ethylene and an α-olefin having 6 to 8 carbon atoms having a density of 0.850 to 0.870 g / cm 3 or less, and 0.4 to 3% by weight. The nucleating agent (C) is added in an amount of 0.05 to 0.5 parts by weight per 100 parts by weight of the resin mixture, and further the phosphorus antioxidant (D) is 0.05 to 0.2 parts by weight, preferably 0.1. -0.15 parts by weight, amine-based antioxidant (E) 0.01-0.1 parts by weight, preferably 0.03-0.06 parts by weight, and calcium stearate or hydrotalcite as a neutralizing agent 02 to 0.2 parts by weight, preferably 0.3 to 0.7 parts by weight, further peroxidation In particular, 2,5-dimethyl-2,5-di (t-butylperoxy) hexane was added and the molecular weight was controlled by an extruder, and the total MFR (230 ° C.) was controlled to a molecular weight of 25 to 40 g / 10 minutes. Is a polypropylene resin composition characterized by

各成分が前記の配合範囲内にあると、樹脂組成物の剛性と透明性を高い水準に保った上で、同時に耐衝撃性の向上を図ることができる。   When each component is within the above-mentioned blending range, the rigidity and transparency of the resin composition can be maintained at a high level, and at the same time, the impact resistance can be improved.

本発明のポリプロピレン系樹脂組成物のMFR(230℃)は、25〜40g/10分にあることが好ましく、より好ましくは27〜33g/10分であることが望ましい。これ以下であると多数個取りの成形においてショートショットや樹脂温度を上げなければならない事による焼け等の成形不具合を生じる。また、これ以上の場合はバリやガスの巻き込みによるボイドといった成形不具合や耐衝撃性低下を招く。   The MFR (230 ° C.) of the polypropylene resin composition of the present invention is preferably 25 to 40 g / 10 minutes, more preferably 27 to 33 g / 10 minutes. If it is less than this, molding defects such as short shots and burning due to the need to raise the resin temperature will occur in the multi-cavity molding. Further, in the case of more than this, molding defects such as burrs and voids due to gas entrainment and impact resistance decrease are caused.

(D)リン系酸化防止剤
本発明で用いられる(D)リン系酸化防止剤としては、特に制限はなく、従来公知のリン系酸化防止剤を用いる事ができる。なお、リン系酸化防止剤を1種類のみ使用することがブリードによる内容物汚染が少ないため好ましい。
(D) Phosphorous antioxidant The (D) phosphorous antioxidant used in the present invention is not particularly limited, and a conventionally known phosphorous antioxidant can be used. In addition, it is preferable to use only one type of phosphorus-based antioxidant because the content contamination due to bleeding is small.

本発明で好ましく用いられるリン系酸化防止剤は3価の有機リン化合物であり、具体的にはトリス(2,4−ジ−t−ブチルフェニル)フォスファイト、2,2−メチレンビス(4,6−ジ−t−ブチルフェニル)オクチルフォスファイト、ビス(2,6−ジ−t−ブチル−4−メチルフェニル)ペンタエリスリトールジフォスファイトなどが挙げられる。   The phosphorus-based antioxidant preferably used in the present invention is a trivalent organic phosphorus compound, specifically, tris (2,4-di-t-butylphenyl) phosphite, 2,2-methylenebis (4,6 -Di-t-butylphenyl) octyl phosphite, bis (2,6-di-t-butyl-4-methylphenyl) pentaerythritol diphosphite, and the like.

(E)アミン系酸化防止剤
本発明で用いられる(E)アミン系酸化防止剤としては、ピペリジン環を持つ化合物が例示される。具体的には、コハク酸ジメチル・1−(2−ヒドロキシエチル)−4−ヒドロキシ−2,2,6,6−テトラメチルピペリジン重縮合物、ビス(2,2,6,6−テトラメチル−4−ピペリジル)セバケートなどが用いられる。
(E) Amine antioxidant The (E) amine antioxidant used in the present invention is exemplified by a compound having a piperidine ring. Specifically, dimethyl succinate 1- (2-hydroxyethyl) -4-hydroxy-2,2,6,6-tetramethylpiperidine polycondensate, bis (2,2,6,6-tetramethyl- 4-piperidyl) sebacate and the like are used.

(F)過酸化物
本発明で用いられる(E)過酸化物としては、2,5−ジメチル−2,5−ジ−(tert−ブチルペルオキシ)ヘキサンが例示される。その他、1,3−ビス(t−ブチルペルオキシ−イソプロピル)ベンゼンなども挙げられるが、特に医療用途であるので、2,5−ジメチル−2,5−ジ−(tert−ブチルペルオキシ)ヘキサンが好適である。
(F) Peroxide The (E) peroxide used in the present invention is exemplified by 2,5-dimethyl-2,5-di- (tert-butylperoxy) hexane. Other examples include 1,3-bis (t-butylperoxy-isopropyl) benzene, but 2,5-dimethyl-2,5-di- (tert-butylperoxy) hexane is preferred because it is particularly for medical use. It is.

注射器外筒
本発明のポリプロピレン系樹脂組成物は、剛性と透明性を高い水準に保った上で、同時に耐衝撃性の向上を図った優れた性質を有しており、且つγ線滅菌後でも高い耐衝撃性を保持しているので、特に注射器外筒として用いることができる。これに加えて、本発明のポリプロピレン系樹脂組成物は、低コストでγ線による処理をしても耐衝撃性の低下が少ないという従来のポリプロピレンでは達成しえない生産性を有している。
Syringe outer cylinder The polypropylene-based resin composition of the present invention has excellent properties in which the rigidity and transparency are kept at a high level, and at the same time, the impact resistance is improved, and even after γ-ray sterilization. Since it has high impact resistance, it can be used particularly as a syringe outer cylinder. In addition to this, the polypropylene resin composition of the present invention has productivity that cannot be achieved with conventional polypropylene, in which the impact resistance is hardly reduced even when treated with γ rays at low cost.

また、この注射器外筒は、ポリプロピレン樹脂組成物において高度に副生成物であるt−ブタノールを削減しているため、注射器外筒においてもt−ブタノールが10ppm以下で生産でき、非常に安全である。   Moreover, since this syringe outer cylinder is highly reducing the t-butanol which is a by-product in a polypropylene resin composition, t-butanol can also be produced in a syringe outer cylinder at 10 ppm or less, and is very safe. .

本発明のポリプロピレン系樹脂組成物には、本発明の目的から逸脱しない範囲内において、必要に応じて、滑剤等の添加剤を配合することができる。なお、電子線またはγ線で処理する用途、例えば医療用器具として用いる場合には、フェノール系酸化防止剤は黄変することがあるので配合することは推奨されない。   The polypropylene resin composition of the present invention can be blended with additives such as a lubricant, if necessary, within a range not departing from the object of the present invention. In addition, when using as an electron beam or a gamma ray, for example, as a medical instrument, it is not recommended to add a phenolic antioxidant because it may turn yellow.

前記した各成分に必要に応じて他の添加剤等をヘンシェルミキサー、V型ブレンダー、タンブラーブレンダー、リボンブレンダーなどを用いて混合した後、単軸押出機、多軸押出機、ニーダー、バンバリーミキサーなどを用いて溶融混練することによって、各成分および添加剤が均一に分散混合された高品質の樹脂組成物を得ることができる。   If necessary, other additives and the like are mixed with each of the above components using a Henschel mixer, a V-type blender, a tumbler blender, a ribbon blender, etc., and then a single screw extruder, a multi screw extruder, a kneader, a Banbury mixer, etc. By melting and kneading using the above, it is possible to obtain a high-quality resin composition in which each component and additive are uniformly dispersed and mixed.

注射器外筒
本発明に係わる注射器外筒は、前記した成分を含む樹脂組成物から射出成形の手段を用いて製造した剛性、透明性、耐衝撃性に優れた注射器外筒であって、且つ電子線やγ線による滅菌処理をしても耐衝撃性の低下が少なく、且つ低コストという従来のポリプロピレンでは達成しえない特徴を有する。この低コストから安価で高品質を追求するディスポーサブル注射筒に特に適している。
Syringe outer cylinder A syringe outer cylinder according to the present invention is a syringe outer cylinder manufactured from a resin composition containing the above-described components by means of injection molding and having excellent rigidity, transparency and impact resistance, and an electronic Even if sterilization treatment with wire or γ-ray is performed, the impact resistance is hardly lowered and the cost is low, which is unattainable with conventional polypropylene. It is particularly suitable for a disposable syringe that pursues high quality from this low cost.

次に実施例を通して本発明を説明するが、本発明はそれら実施例によって何ら限定されるものではない。   EXAMPLES Next, the present invention will be described through examples, but the present invention is not limited to the examples.

実施例で使用した原料は以下のとおりである。
(A−1)エチレン−プロピレンランダム共重合体:
MFR(230℃);12g/10分
エチレン含有量;4.0重量%
(A−2)エチレン−プロピレンランダム共重合体
MFR(230℃);12g/10分
エチレン含有量;2.6重量%
(A−3)エチレン−プロピレンランダム共重合体
MFR(230℃);4g/10分
エチレン含有量;4.0重量%
(B−1)エチレン・1−オクテン共重合体:
MFR(190℃);4g/10分
密度;0.860g/cm
(B−2)エチレン・1−オクテン共重合体:
MFR(190℃);4g/10分
密度;0.910g/cm
(C−1)造核剤;
ヒドロキシアルミニウム−ビス[2,2−メチレン−ビス(4,6−ジ−t−ブチルフェニル)フォスフェート](主成分) 商品名NA−21(旭電化製)
(C−2)造核剤;
ナトリウム−2,2'−メチレンビス(4,6−ジ−tert−ブチルフェニル)ホスフェート〔商品名:NA−11UY(旭電化製)〕
The raw materials used in the examples are as follows.
(A-1) Ethylene-propylene random copolymer:
MFR (230 ° C.); 12 g / 10 minutes Ethylene content; 4.0% by weight
(A-2) Ethylene-propylene random copolymer MFR (230 ° C.); 12 g / 10 minutes Ethylene content; 2.6% by weight
(A-3) ethylene-propylene random copolymer MFR (230 ° C.); 4 g / 10 min. Ethylene content; 4.0% by weight
(B-1) Ethylene / 1-octene copolymer:
MFR (190 ° C.); 4 g / 10 min Density; 0.860 g / cm 3
(B-2) Ethylene / 1-octene copolymer:
MFR (190 ° C.); 4 g / 10 minutes Density; 0.910 g / cm 3
(C-1) nucleating agent;
Hydroxyaluminum-bis [2,2-methylene-bis (4,6-di-t-butylphenyl) phosphate] (main component) Product name NA-21 (manufactured by Asahi Denka)
(C-2) nucleating agent;
Sodium-2,2'-methylenebis (4,6-di-tert-butylphenyl) phosphate [trade name: NA-11UY (Asahi Denka)]

本発明において、物性は次の方法で測定した。
(イ)ヘイズ:ASTM D1003に準拠し、2mmシートを用いて測定した。
(ロ)曲げ弾性率:ASTM D790に準拠して曲げ試験を行い、その結果から曲げ弾
性率を算出した。
(ハ)高速面衝撃試験:3m/sの速度で先端径1/2インチのロードセル付き撃芯を2mm厚み角板の5℃雰囲気の試料に衝突させる。試料の裏面には受け台として先端径(受け径)3インチの台を使用した。値としては、全吸収エネルギーと降伏してから破壊するまでの延性エネルギーをそれぞれ求めた。
(ニ)引張り降伏強さおよび破断点伸び:ASTM D−638に準拠して曲げ試験を行いその結果から引張り降伏点強さおよび破断点伸びを測定した。
(ヘ)メルトフローレート(MFR):ASTM D−1238に準拠し、荷重2.16Kgで、都度表示した温度で測定した。例えば、190℃で測定した場合MFR(190℃)と表示した。
In the present invention, physical properties were measured by the following methods.
(I) Haze: Measured using a 2 mm sheet in accordance with ASTM D1003.
(B) Bending elastic modulus: A bending test was performed according to ASTM D790, and the bending elastic modulus was calculated from the result.
(C) High-speed surface impact test: A striker with a load cell having a tip diameter of 1/2 inch is made to collide with a sample in a 5 ° C. atmosphere of a 2 mm thick square plate at a speed of 3 m / s. A base having a tip diameter (receiving diameter) of 3 inches was used as a receiving base on the back surface of the sample. As values, the total absorbed energy and the ductile energy from yielding to breaking were obtained.
(D) Tensile yield strength and elongation at break: A bending test was performed in accordance with ASTM D-638, and the tensile yield strength and elongation at break were measured from the results.
(F) Melt flow rate (MFR): Measured according to ASTM D-1238, with a load of 2.16 kg, and at the indicated temperature. For example, when measured at 190 ° C., MFR (190 ° C.) is displayed.

(実施例1)
ヘンシェルミキサー中にエチレン−プロピレンランダム共重合体(A−1)97重量部、エチレン・1−オクテン共重合体(B−1)3重量部を供給し、さらにリン系酸化防止剤[トリス(2,4−ジ−t−ブチルフェニル)フォスファイト]0.1重量部、造核剤(C)0、25重量部、ステアリン酸カルシウム0.1重量部、2,5−ジメチル−2,5−ジ−(tert−ブチルペルオキシ)ヘキサンを0.03重量部添加し、攪拌混合した。その混合物を二軸押出機(40mmφ)を用いて樹脂温度220℃で溶融混練し、その混練物を押し出して水中冷却しカットし、ポリプロピレン系樹脂組成物のペレットを得た。このペレットを110℃で8時間乾燥した。
(Example 1)
In a Henschel mixer, 97 parts by weight of an ethylene-propylene random copolymer (A-1) and 3 parts by weight of an ethylene / 1-octene copolymer (B-1) were supplied, and a phosphorous antioxidant [Tris (2 , 4-di-t-butylphenyl) phosphite] 0.1 parts by weight, nucleating agent (C) 0, 25 parts by weight, calcium stearate 0.1 parts by weight, 2,5-dimethyl-2,5-di 0.03 part by weight of (tert-butylperoxy) hexane was added and mixed with stirring. The mixture was melt-kneaded at a resin temperature of 220 ° C. using a twin screw extruder (40 mmφ), and the kneaded product was extruded, cooled in water and cut to obtain a polypropylene resin composition pellet. The pellet was dried at 110 ° C. for 8 hours.

次いで、そのペレットを用いて射出成形により190℃、金型温度40℃にて厚み2mmのシート状試験片、曲げ強度試験用の試験片(ASTM D790、厚み3.2mm、長さ127mm、幅12.7mm)、およびアイゾット衝撃試験用の試験片(ASTM D256、厚み3.2mm、長さ63.5mm、幅1.7mm)をそれぞれ作製した。これら試験片にγ線20kGy照射し、この試験片を用いて、ヘイズ、曲げ弾性率、高速面衝撃試験吸収エネルギー、引張り降伏強さおよび破断点伸びを測定し、その結果を表1に示した。   Next, using the pellets, a sheet-shaped test piece having a thickness of 2 mm at 190 ° C. and a mold temperature of 40 ° C. by injection molding, a test piece for bending strength test (ASTM D790, thickness 3.2 mm, length 127 mm, width 12) And 7 mm), and Izod impact test specimens (ASTM D256, thickness 3.2 mm, length 63.5 mm, width 1.7 mm), respectively. These test pieces were irradiated with γ-rays of 20 kGy, and using this test piece, haze, bending elastic modulus, high-speed surface impact test absorbed energy, tensile yield strength and elongation at break were measured, and the results are shown in Table 1. .

(実施例2)
実施例1において、エチレン−プロピレンランダム共重合体(A−1)の配合量を98.5重量部、エチレン・1−オクテン共重合体(B−1)の配合量を1.5重量部に変更した以外は実施例1と同様に行った。物性測定結果を表1に示した。
(Example 2)
In Example 1, the blending amount of the ethylene-propylene random copolymer (A-1) is 98.5 parts by weight, and the blending amount of the ethylene / 1-octene copolymer (B-1) is 1.5 parts by weight. The procedure was the same as in Example 1 except for the change. The physical property measurement results are shown in Table 1.

(実施例3)
実施例1において、エチレン−プロピレンランダム共重合体(A−1)の配合量を99重量部、エチレン・1−オクテン共重合体(B−1)の配合量を1重量部に変更した以外は実施例1と同様に行った。物性測定結果を表1に示した。
(Example 3)
In Example 1, the blending amount of the ethylene-propylene random copolymer (A-1) was changed to 99 parts by weight, and the blending amount of the ethylene / 1-octene copolymer (B-1) was changed to 1 part by weight. The same operation as in Example 1 was performed. The physical property measurement results are shown in Table 1.

(実施例4)
実施例1において、エチレン−プロピレンランダム共重合体(A−1)を、エチレン−プロピレンランダム共重合体(A−3)に変更した以外は実施例1と同様に行った。物性測定結果を表1に示した。
Example 4
In Example 1, it carried out like Example 1 except having changed the ethylene-propylene random copolymer (A-1) into the ethylene-propylene random copolymer (A-3). The physical property measurement results are shown in Table 1.

(比較例1)
実施例1において、エチレン・1−オクテン共重合体(B−1)を用いずに、エチレン−プロピレンランダム共重合体(A−1)の配合量を100重量部とした以外は実施例1と同様に行った。物性測定結果を表1に示した。
(Comparative Example 1)
Example 1 is the same as Example 1 except that the blending amount of the ethylene-propylene random copolymer (A-1) is 100 parts by weight without using the ethylene / 1-octene copolymer (B-1). The same was done. The physical property measurement results are shown in Table 1.

(比較例2)
実施例1において、エチレン−プロピレンランダム共重合体(A−1)の配合量を95重量部、エチレン・1−オクテン共重合体(B−1)の配合量を5重量部に変更した以外は実施例1と同様に行った。物性測定結果を表1に示した。
(Comparative Example 2)
In Example 1, except that the blending amount of the ethylene-propylene random copolymer (A-1) was changed to 95 parts by weight and the blending amount of the ethylene / 1-octene copolymer (B-1) was changed to 5 parts by weight. The same operation as in Example 1 was performed. The physical property measurement results are shown in Table 1.

(比較例3)
実施例1において、エチレン−プロピレンランダム共重合体(A−1)の代わりにエチレン−プロピレンランダム共重合体(A−2)を用いた以外は実施例1と同様に行った。物性測定結果を表1に示した。
(Comparative Example 3)
In Example 1, it carried out like Example 1 except having used ethylene-propylene random copolymer (A-2) instead of ethylene-propylene random copolymer (A-1). The physical property measurement results are shown in Table 1.

(比較例4)
比較例3においてエチレン−プロピレンランダム共重合体(A−1)の配合量を90重量部、エチレン・1−オクテン共重合体(A−2)の配合量を10重量部に変更した以外は比較例3と同様に行った。物性測定結果を表1に示した。
(Comparative Example 4)
In Comparative Example 3, except that the blending amount of the ethylene-propylene random copolymer (A-1) was changed to 90 parts by weight and the blending amount of the ethylene / 1-octene copolymer (A-2) was changed to 10 parts by weight. Performed as in Example 3. The physical property measurement results are shown in Table 1.

(比較例5)
実施例1において造核剤(C−1)の代わりに(C−2)を用いた以外は実施例1と同様に行った。物性測定結果を表1に示した。
(Comparative Example 5)
The same procedure as in Example 1 was performed except that (C-2) was used instead of the nucleating agent (C-1) in Example 1. The physical property measurement results are shown in Table 1.

(比較例6)
実施例1において、エチレン・1−オクテン共重合体(B−1)の代わりに、エチレン・1−オクテン共重合体(B−2)を用いた以外は実施例1と同様に行った。物性測定結果を表1に示した。
(Comparative Example 6)
In Example 1, it carried out like Example 1 except having used ethylene / 1-octene copolymer (B-2) instead of ethylene / 1-octene copolymer (B-1). The physical property measurement results are shown in Table 1.

Figure 2005325333
Figure 2005325333

表1に記載した物性測定結果から、本発明に係わるポリプロピレン系樹脂組成物が透明性を維持したまま耐衝撃性を有し、またそれらの値が高度にバランスされていることがわかる。この樹脂組成物の場合、高価なゴムを微量添加で済むためコストアップは非常に小さい。γ線照射後の耐衝撃性低下はほとんど見られず、今までのコストでは到達しえないポリプロピレン樹脂組成物物性を示しており、非常に有用である。   From the physical property measurement results shown in Table 1, it can be seen that the polypropylene resin composition according to the present invention has impact resistance while maintaining transparency, and those values are highly balanced. In the case of this resin composition, the cost increase is very small because a small amount of expensive rubber can be added. The impact resistance reduction after γ-ray irradiation is hardly seen, and the physical properties of the polypropylene resin composition that cannot be achieved at the conventional cost are shown, which is very useful.

非常に狭い組成範囲でのみこのような良好な透明性を保持した上に、γ線照射後も高い耐衝撃性と剛性をバランスでき、且つ低コストという今までに無い材料を開発できた。5℃での耐衝撃性が飛躍的に改良できており、冬場の割れ問題、針装着時の折れ問題を解決でき、この材料は、安価な使い捨て注射器外筒に好適である。
In addition to maintaining such good transparency only in a very narrow composition range, it has been possible to develop an unprecedented material that can balance high impact resistance and rigidity after γ-ray irradiation and is low in cost. The impact resistance at 5 ° C. can be drastically improved, and it can solve the problem of cracking in winter and the problem of breaking at the time of wearing a needle, and this material is suitable for an inexpensive disposable syringe outer cylinder.

Claims (8)

(A)MFR(230℃)が4〜20g/10分、エチレン含有量が3.6〜4.2重量%のポリプロピレン97〜99.6重量%、
(B)MFR(190℃)が2〜6g/10分であり、かつ密度が0.850〜0.870g/cm以下であるエチレンと炭素数6〜8のα−オレフィンとの共重合体0.4〜3重量%、
とからなる樹脂混合物100重量部当たり、
(C)下記式(1)で表わされる造核剤を0.05〜0.5重量部配合して過酸化物により、更に全MFR(230℃)を25〜40g/10分に分子量コントロールしたことを特徴とするポリプロピレン系樹脂組成物。
Figure 2005325333
(A) 97 to 99.6% by weight of polypropylene having an MFR (230 ° C.) of 4 to 20 g / 10 minutes, an ethylene content of 3.6 to 4.2% by weight,
(B) a copolymer of ethylene and an α-olefin having 6 to 8 carbon atoms having an MFR (190 ° C.) of 2 to 6 g / 10 min and a density of 0.850 to 0.870 g / cm 3 or less 0.4 to 3% by weight,
Per 100 parts by weight of the resin mixture consisting of
(C) 0.05 to 0.5 parts by weight of a nucleating agent represented by the following formula (1) was added, and the total MFR (230 ° C.) was further controlled to a molecular weight of 25 to 40 g / 10 minutes by peroxide. A polypropylene resin composition characterized by that.
Figure 2005325333
前記の(B)エチレン・α−オレフィン共重合体が、メタロセン触媒によって製造された重合体であることを特徴とする請求項1に記載のポリプロピレン系樹脂組成物。 The polypropylene resin composition according to claim 1, wherein the (B) ethylene / α-olefin copolymer is a polymer produced by a metallocene catalyst. 前記(A)ポリプロピレンと(B)エチレン・α−オレフィン共重合体とからなる樹脂混合物100重量部当たり、リン系酸化防止剤(D)0.05〜0.3重量部およびアミン系酸化防止剤(E)0.01〜0.3重量部が含有された請求項1または2に記載のポリプロピレン系樹脂組成物。 Phosphorous antioxidant (D) 0.05 to 0.3 parts by weight and amine antioxidant per 100 parts by weight of the resin mixture comprising (A) polypropylene and (B) ethylene / α-olefin copolymer (E) The polypropylene-type resin composition of Claim 1 or 2 containing 0.01-0.3 weight part. 請求項1〜3のいずれか1項に記載の樹脂組成物に上記式(1)の分散材として脂肪酸金属塩を添加したことを特徴とするポリプロピレン樹脂組成物。 A polypropylene resin composition, wherein a fatty acid metal salt is added to the resin composition according to any one of claims 1 to 3 as a dispersing agent of the formula (1). 請求項1〜4のいずれか1項に記載のポリプロピレン樹脂組成物に含有される過酸化物からの副生成物であるt−ブタノールが100ppm以下である事を特徴とするポリプロピレン樹脂組成物。 The polypropylene resin composition characterized by that t-butanol which is a by-product from the peroxide contained in the polypropylene resin composition according to any one of claims 1 to 4 is 100 ppm or less. 請求項1〜5のいずれか1項に記載のポリプロピレン系樹脂組成物から形成されてなることを特徴とする組成物を射出成形によって形成されてなることを特徴とする注射器外筒。 A syringe outer cylinder comprising a composition formed from the polypropylene-based resin composition according to any one of claims 1 to 5 and formed by injection molding. 注射器外筒が、電子線、特にγ線照射による滅菌を施されることを特徴とする請求項6記載の医療用ディスポーザル注射器外筒。 7. The medical disposable syringe outer cylinder according to claim 6, wherein the syringe outer cylinder is sterilized by electron beam irradiation, particularly γ-ray irradiation. 請求項6または7の注射器外筒から検出されるt−ブタノールが10ppm以下である事を特徴とする注射器外筒。 A syringe outer cylinder, wherein t-butanol detected from the syringe outer cylinder according to claim 6 or 7 is 10 ppm or less.
JP2005057114A 2004-04-16 2005-03-02 Polypropylene resin composition and syringe outer cylinder comprising the composition Active JP4808419B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005057114A JP4808419B2 (en) 2004-04-16 2005-03-02 Polypropylene resin composition and syringe outer cylinder comprising the composition

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004121286 2004-04-16
JP2004121286 2004-04-16
JP2005057114A JP4808419B2 (en) 2004-04-16 2005-03-02 Polypropylene resin composition and syringe outer cylinder comprising the composition

Publications (2)

Publication Number Publication Date
JP2005325333A true JP2005325333A (en) 2005-11-24
JP4808419B2 JP4808419B2 (en) 2011-11-02

Family

ID=35471922

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005057114A Active JP4808419B2 (en) 2004-04-16 2005-03-02 Polypropylene resin composition and syringe outer cylinder comprising the composition

Country Status (1)

Country Link
JP (1) JP4808419B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5351754B2 (en) * 2007-04-25 2013-11-27 三井化学株式会社 Method for producing thermoplastic elastomer composition and molded body
WO2017126550A1 (en) * 2016-01-20 2017-07-27 テルモ株式会社 Synthetic-resin outer cylinder for syringe, syringe, prefilled syringe, and liquid-filled sterilized synthetic-resin container
WO2021196331A1 (en) * 2020-04-01 2021-10-07 山西省化工研究所(有限公司) Nucleating agent for polyolefin

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117677665A (en) 2021-06-09 2024-03-08 博里利斯股份公司 Polypropylene composition
EP4335881A1 (en) 2022-09-09 2024-03-13 Borealis AG Polypropylene composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0977930A (en) * 1995-09-18 1997-03-25 Tonen Chem Corp Polypropylene resin composition improved in high-speed moldability and transparency
JP2002226649A (en) * 2001-02-06 2002-08-14 Terumo Corp Outer cylinder for syringe
JP2002275332A (en) * 2001-03-15 2002-09-25 Mitsui Chemicals Inc Polypropylene resin composition and use thereof
JP2003072730A (en) * 2001-08-31 2003-03-12 Idemitsu Petrochem Co Ltd Transparent polypropylene container

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0977930A (en) * 1995-09-18 1997-03-25 Tonen Chem Corp Polypropylene resin composition improved in high-speed moldability and transparency
JP2002226649A (en) * 2001-02-06 2002-08-14 Terumo Corp Outer cylinder for syringe
JP2002275332A (en) * 2001-03-15 2002-09-25 Mitsui Chemicals Inc Polypropylene resin composition and use thereof
JP2003072730A (en) * 2001-08-31 2003-03-12 Idemitsu Petrochem Co Ltd Transparent polypropylene container

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5351754B2 (en) * 2007-04-25 2013-11-27 三井化学株式会社 Method for producing thermoplastic elastomer composition and molded body
WO2017126550A1 (en) * 2016-01-20 2017-07-27 テルモ株式会社 Synthetic-resin outer cylinder for syringe, syringe, prefilled syringe, and liquid-filled sterilized synthetic-resin container
WO2021196331A1 (en) * 2020-04-01 2021-10-07 山西省化工研究所(有限公司) Nucleating agent for polyolefin

Also Published As

Publication number Publication date
JP4808419B2 (en) 2011-11-02

Similar Documents

Publication Publication Date Title
JP5419871B2 (en) Irradiated polyolefin compositions containing non-phenolic stabilizers
US20100324225A1 (en) Controlled-Rheology Polypropylene
JP4808419B2 (en) Polypropylene resin composition and syringe outer cylinder comprising the composition
JP4628870B2 (en) PROPYLENE RESIN COMPOSITION AND SYMBOL OUTLET AND FOOD CONTAINER COMPRISING THE COMPOSITION
JP2002105257A (en) Polypropylene resin composition, and container and medical appliance made of the same
KR870002104B1 (en) Radiation stable polypropylene resin composition
EP1931731B1 (en) Propylene copolymer compositions
JPH0551023B2 (en)
EP3327083B1 (en) Polypropylene resin composition and molded body for medical use, which uses same
US20050119380A1 (en) Polypropylene resin composition
JP4236995B2 (en) Polypropylene resin composition and use thereof
JP2004182955A (en) Propylene resin composition and use of the same
JP2006083218A (en) Propylenic resin composition and blow molded article comprising the composition
JP2002097322A (en) Polypropylene-based resin composition and molded product therefrom
JP2005314490A (en) Polypropylene resin composition and medical equipment therefrom, prefilled syringe
JP7178773B2 (en) Polypropylene resin composition and medical molded article using the same
KR101913911B1 (en) Composition of α-olefin propylene copolymer resistant to γ ray irradiation
JP4087266B2 (en) Polypropylene resin composition and use thereof
JPS61159437A (en) Propylene polymer mixture
JP2005015772A (en) Ethylene-propylene block copolymer, propylene resin composition comprising the same and its application
KR20130000129A (en) Polypropylene resin composition, manufacturing method thereof and film manufactured by thereof
JP3697329B2 (en) Polypropylene composition
JP3339033B2 (en) Polypropylene composition
KR102125637B1 (en) Polyolefin composition
JP3175260B2 (en) Polypropylene resin composition

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20060215

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20060530

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080226

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20090817

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20101110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110106

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110809

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110817

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140826

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4808419

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250